SCHEMBL4869060

SCHEMBL4869060

CN(C)CC1COCCC1=O

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 5/20 0.34
CCR6 P51684 1/20 0.33
MITF O75030 1/20 0.31
HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4870207 0.98 METAP1 (0.36) METAP1CCR6MITFHSP90AA1
SCHEMBL3327529 0.78
SCHEMBL14169479 0.74 NOS1 (0.38)
SCHEMBL14635516 0.74
SCHEMBL3325656 0.73 PDK1 (0.32)
SCHEMBL13899831 0.73
SCHEMBL358873 0.72 TLR4 (0.33)
SCHEMBL3024107 0.71 MT-CO2 (0.37) HSP90AA1
SCHEMBL14101011 0.71 NOS2 (0.30)
SCHEMBL8554107 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3750883-B1 AMINOALKYL COMPOUND DAIICHI SANKYO CO LTD (JP) 2023-10-04 EP disclosed
CN-111655675-B Aminoalkyl compounds 第一三共株式会社 2023-09-22 CN disclosed
US-11440896-B2 Aminoalkyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-09-13 US disclosed
US-20210040057-A1 AMINOALKYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-02-11 US disclosed
EP-3750883-A1 AMINOALKYL COMPOUND Daiichi Sankyo Company, Limited (JP) 2020-12-16 EP disclosed
US-7384961-B2 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants GRUENENTHAL GMBH (DE) 2008-06-10 US disclosed
EP-1572653-B1 SATURATED AND UNSATURATED HETEROARYLCYCLOALKYLMETHYL AMINES AS ANTI-DEPRESSANTS GRUENENTHAL GMBH (DE) 2007-11-21 EP disclosed
US-20060025456-A1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants GRUENENTHAL GMBH (DE) 2006-02-02 US disclosed
EP-1572653-A1 SATURATED AND UNSATURATED HETEROARYLCYCLOALKYLMETHYL AMINES AS ANTI-DEPRESSANTS Grünenthal GmbH (DE) 2005-09-14 EP disclosed
WO-2004063161-A1 SATURATED AND UNSATURATED HETEROARYLCYCLOALKYLMETHYL AMINES AS ANTI-DEPRESSANTS Grünenthal GmbH (DE) 2004-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040057-A1 AMINOALKYL COMPOUND TRPA1, TRPV1, TRPV5 METAP1 661/4885CCR6 791/4885MITF 1708/4885
US-20060025456-A1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants OPRK1, OPRM1, HTR1A METAP1 3260/4885CCR6 4184/4885MITF 1534/4885
US-11440896-B2 Aminoalkyl compound TRPA1, TRPV1, TRPV5 METAP1 661/4885CCR6 791/4885MITF 1708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.